Who makes Intensive 5% sodium fluoride?

Intensive 5% sodium fluoride is developed by Riyadh Elm University.

What development phase is Intensive 5% sodium fluoride in?

Intensive 5% sodium fluoride is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Intensive 5% sodium fluoride

Riyadh Elm University · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Intensive 5% sodium fluoride
Also known as	EnamelastTM
Sponsor	Riyadh Elm University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

White Spot Lesions Treatment in Orthodontic (PHASE4)
Effect of Casein Phosphopeptide Amorphous Calcium Phosphate Fluoride Varnish on Remineralization of White Spot Lesion in Primary Teeth (PHASE2)
A Systematic Oral Care Program in Post-Mechanically Ventilated, Post-Intensive Care Patients (NA)
Arresting Active Dental Caries in Preschool Children by Topical Fluorides (PHASE2, PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Intensive 5% sodium fluoride CI brief — competitive landscape report
Intensive 5% sodium fluoride updates RSS · CI watch RSS
Riyadh Elm University portfolio CI